Resources
- Key Takeaways
- Test Yourself
- Video Lecture
G-protein-coupled receptors (GPCRs), also called metabotropic receptors, are membrane-bound proteins that activate G-proteins after binding neurotransmitters. Like ionotropic receptors, metabotropic receptors are primarily located along the dendrites or cell body, but they can be present anywhere along the neuron if there is a synapse. Metabotropic receptors are also important for receiving incoming information from other neurons. GPCRs have slower effects than ionotropic receptors, but they can have long-lasting effects, unlike the brief action of a postsynaptic potential.
G-proteins are enzymes with three subunits: alpha, beta, and gamma. In the resting state of the G-protein complex, the alpha subunit is bound to a GDP molecule. There are multiple types of alpha subunits, and each initiate different cellular cascades in the neuron.
When a neurotransmitter binds to a GPCR, the receptor is able to interact with an inactivated G-protein complex. The complex that binds is specific to the receptor; different metabotropic receptors for the same neurotransmitter can have different effects in the cell due to which G-protein binds. Once coupled to the receptor, the GDP molecule is exchanged for a GTP molecule, and the G-protein becomes activated.
Animation 12.1. Neurotransmitter binding to a G-protein-coupled receptor causes the inactivated G-protein complex to interact with the receptor. The GDP molecule is then exchanged for a GTP molecule, which activates the G-protein complex. ‘G-protein Binding’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
After activation, the G-protein complex will separate into the alpha-GTP subunit and the beta-gamma subunit. Both components can alter the function of effector proteins in the cell. Effector protein functions can range from altering ion permeability across the membrane by opening ion channels to initiating second messenger cascades. Second messenger cascades can have long-term, widespread, and diverse cellular effects including activation of cellular enzymes or altering gene transcription.
Animation 12.2. Once activated, the G-protein complex will separate into the alpha-GTP subunit and the beta-gamma subunit. These subunits can stimulate or inhibit effector proteins within the cell. ‘G-protein Effects’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
Open Ion Channels – Beta Gamma Subunit
Metabotropic receptors can indirectly open ion channels; this process is slower than ionotropic receptors
In certain situations, the activated beta-gamma subunit can open or close ion channels and change membrane permeability. Muscarinic acetylcholine receptors in the heart use this pathway. When acetylcholine binds to a muscarinic receptor in the heart muscle fiber, the activated beta-gamma subunit opens a type of potassium channel called G-protein-coupled inwardly-rectifying potassium (GIRK) channel, hyperpolarizing the cell. This inhibitory effect explains why acetylcholine or an agonist like atropine slow the heart rate.
Animation 12.3. Some GPCRs, like the muscarinic acetylcholine receptors in the heart, alter cellular permeability by opening ion channels. The activated beta-gamma subunit of the muscarinic receptor opens GIRK potassium channels and allows the efflux of potassium. ‘Beta-Gamma Ion Channels’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
Second Messenger Cascades
Metabotropic receptors can alter protein function in the cell through second messenger cascades; these cascades may lead to changes in gene transcription
In addition to direct effects like the activated beta-gamma subunit opening ion channels, G-proteins can have many indirect actions in the cell through the use of second messenger cascades. The specific second messenger pathway that is activated or suppressed by G-protein action depends on the type of alpha subunit.
For example, norepinephrine can act on either alpha- or beta-adrenergic receptors. Beta-adrenergic GPCRs couple to a stimulatory G-protein, or Gs, which initiates the cyclic AMP (cAMP) second messenger system by activating the enzyme adenylyl cyclase. Alpha 2-adrenergic receptors, however, couple to an inhibitory G-protein, or Gi, and suppress the activity of adenylyl cyclase. Alpha 1-adrenergic receptors couple to a third type of G-protein, Gq, which activates the phospholipase C pathway. One neurotransmitter can, therefore, cause a wide range of cellular effects after binding to GPCRs, unlike the single function of ion flow through the ionotropic receptors. The pathway initiated by norepinephrine will depend on the type of receptor a specific cell expresses.
Adenylyl Cyclase / cAMP Second Messenger Cascade
The cyclic AMP (cAMP) second messenger pathway is used by many GPCRs. Activation of the pathway is caused by the Gs alpha subunit and inhibition of the pathway is caused by the Gi alpha subunit. When activated, adenylyl cyclase converts ATP to cAMP in the cytoplasm. cAMP then activates another enzyme called protein kinase A (PKA) by binding to the regulatory subunits, allowing the catalytic (functional) subunits to separate and become active. Protein kinases add a phosphate molecule to proteins, a mechanism called phosphorylation. The addition of the phosphate changes the activity of the protein and how it functions in the cell.
Animation 12.4. GPCRs that couple to the Gs alpha subunit initiate the adenylyl cyclase / cAMP pathway. The Gs subunit activates adenylyl cyclase, which then converts ATP to cAMP. cAMP binds to and activates protein kinase A (PKA), which phosphorylates proteins in the cell. ‘Adenylyl Cyclase Pathway’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
The end effects of this pathway will depend on which proteins are targeted. For example, cAMP can gate ion channels and PKA can phosphorylate ion channels altering permeability and membrane potential. Phosphorylation can open the channel, or it may modulate the activity of the channel, making the channel easier to open or remain open longer.
Animation 12.5. The adenylyl cyclase / cAMP pathway can alter many cellular functions. One example is that both cAMP and PKA can open ion channels. Like ligand-gated channels, there are also cAMP-gated channels, which open after cAMP binding. PKA is able to phosphorylate and modulate ion channel function by converting ATP to ADP. ‘Second Messenger Ion Channel Action’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
In addition to altering ion channel function, PKA can phosphorylate other proteins important for neuron function, such as proteins involved with neurotransmitter synthesis and release. One other critical target of PKA phosphorylation is the transcription factor CREB (cAMP response element binding-protein). Transcription factors bind to DNA in the nucleus and change the rate of gene transcription. Phosphorylation by PKA can cause CREB to initiate transcription of genes, creating new proteins for the neuron. Depending on which genes are transcribed, the effects on the neuron can be long-lasting.
Overall, neurotransmitters working through GPCRs and second messenger cascades like the adenylyl cyclase pathway can cause a diverse range of cellular effects: from opening ion channels, to changing protein activity via phosphorylation, to altering the proteins synthesized in the neuron.
Animation 12.6. PKA can phosphorylate a number of proteins involved with neuron function. It can target proteins involved with neurotransmitter synthesis, packing, and release, or it can enter the nucleus and phosphorylate CREB, a transcription factor that can initiate gene transcription and protein synthesis. ‘PKA Targets’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
Phospholipase C / IP3 / DAG Second Messenger Cascade
The Gq alpha subunit initiates a separate signaling pathway in the cell by activating phospholipase C. Phospholipase C targets PIP2 (phosphatidylinositol 4,5-bisphosphate), which is a phospholipid present in the plasma membrane of the cell. PIP2 is split into two cellular molecules: IP3 (inositol 1,4,5-trisphosphate) and DAG (diacylglycerol). DAG remains in the membrane and interacts with protein kinase c (PKC). IP3 moves to the endoplasmic reticulum where it opens calcium channels and allows calcium to flow into the cytosol.
Calcium is also a second messenger in the cell. One important effect is the binding of calcium to calmodulin protein. This complex can then activate another kinase, the calcium/calmodulin-dependent protein kinase (CaMK). Both PKC and CaMK can phosphorylate specific cellular and nuclear proteins like PKA.
Animation 12.7. The Gq G-protein subunit activates phospholipase C, which converts the phospholipid PIP2 in the cell membrane into DAG, another membrane-bound molecule, and IP3, a cytoplasmic molecule. DAG can interact with PKA, initiating phosphorylation of cellular proteins. IP3 opens calcium channels in the endoplasmic reticulum, allowing calcium to flow into the cytoplasm. Calcium, another second messenger can have many cellular effects. It can bind to calmodulin, which then activates CaMK, causing phosphorylation of more protein targets. ‘IP3-DAG Pathway’ by Casey Henley is licensed under a Creative Commons Attribution Non-Commercial Share-Alike (CC BY-NC-SA) 4.0 International License. View static image of animation.
One characteristic of GPCR activation is the signal amplification that takes place. One receptor is able to activate more than one G-protein complex. The effector protein activated by the G-protein can create many second messengers, and the activated protein kinases can each phosphorylate multiple cellular proteins. This means that one neurotransmitter can have a significant effect on cellular function.
Eventually, the cascade initiated by binding of the neurotransmitter to the GPCR needs to end. The alpha subunit of the G-protein is able to convert the bound GTP back to GDP after a short period of time, inactivating the G-protein. The alpha subunit will then interact with a beta-gamma subunit and stay in the resting state until activated by another GPCR. Enzymes in the cell called protein phosphatases find and remove the phosphate groups added to cellular proteins by the protein kinases. And finally, other cellular mechanisms exist to remove calcium from the cytoplasm and degrade other second messengers.
Key Takeaways
- G-protein-coupled receptors rely on the activation of G-proteins to cause cellular changes
- G-protein-coupled receptors have slower effects than ligand-gated receptors
- G-proteins can open ion channels, alter protein function via phosphorylation, and alter gene transcription
- The Gs subunit initiates the adenylyl cyclase / cAMP signaling pathway
- The Gi subunit inhibits the adenylyl cyclase / cAMP signaling pathway
- The Gq subunit initiates the phospholipase C / IP3 / DAG signaling pathway
Test Yourself!
- What are some differences between ionotropic and metabotropic neurotransmitter receptors?
FAQs
What is GPCR in neuroscience? ›
G-protein-coupled receptors (GPCRs) are one of the most frequently targeted receptors for developing novel therapeutics for central nervous system (CNS) disorders. Many currently available antipsychotic therapeutics also act as either antagonists or agonists of different GPCRs.
What is the importance of G-protein-coupled receptors? ›G protein-coupled receptors (GPCRs) mediate our sense of vision, smell, taste, and pain. They are also involved in cell recognition and communication processes, and hence have emerged as a prominent superfamily for drug targets.
Which G proteins stimulate neuronal activity? ›Astroglial activation by either Gq or Gi/o protein-mediated signaling stimulated gliotransmitter release, which increased neuronal excitability. Additionally, activation of Gq and Gi/o DREADDs in vivo increased astrocyte Ca2+ activity and modified neuronal network electrical activity.
What are G-protein-coupled receptors and how do they work? ›G protein coupled receptors (GPCRs) are integral membrane proteins that are used by cells to convert extracellular signals into intracellular responses, including responses to hormones, neurotransmitters, as well as responses to vision, olfaction and taste signals.
Are GPCRs used in neuronal signaling? ›Introduction. G protein-coupled receptors (GPCRs) are key players in neuronal communication, modulating synaptic transmission both at the pre- and post-synaptic levels. As such, they remain promising targets for the treatment of a number of brain diseases.
What do G protein receptors activate? ›G protein activation leads to activation of various second messenger systems and intracellular responses, leading to physiological responses of tissues and organisms. In the inactive heterotrimeric state, GDP is bound to the Gα subunit.
What is the primary role of G-protein? ›The main physiological functions of G-proteins are to relay the signals from GPCRs which function as GEFs for G-proteins. Binding with exogenous or endogenous agonists induces GPCRs into an active conformational state which, in turn, influences intracellular binding of G-proteins or arrestin proteins [23, 24].
What are G proteins responsible for? ›G proteins regulate metabolic enzymes, ion channels, transporter proteins, and other parts of the cell machinery, controlling transcription, motility, contractility, and secretion, which in turn regulate diverse systemic functions such as embryonic development, learning and memory, and homeostasis.
What drugs use G protein coupled receptors? ›Hence, there is enormous potential for the development of new drugs targeting these receptors. Examples of drugs targeting GPCRs include histamine receptor blockers, opioid agonists, β-blockers and angiotensin receptor blockers.
What signals do G protein coupled receptors detect? ›G Protein Coupled Receptors (GPCRs) perceive many extracellular signals and transduce them to heterotrimeric G proteins, which further transduce these signals intracellular to appropriate downstream effectors and thereby play an important role in various signaling pathways.
How are G protein receptors regulated? ›
GPCR signaling is tightly regulated by various mechanisms, including internalization, desensitization, and interaction with cytosolic proteins. These mechanisms are influenced by posttranslational modifications such as phosphorylation, glycosylation, palmitoylation and ubiquitination [15,16,17,18].
What are 4 examples of GPCRs? ›Some examples of GPCRs include beta-adrenergic receptors, which bind epinephrine; prostaglandin E2 receptors, which bind inflammatory substances called prostaglandins; and rhodopsin, which contains a photoreactive chemical called retinal that responds to light signals received by rod cells in the eye.
Which of the following best summarizes the function of G proteins? ›Which of the following statements best summarizes the function of G protein-coupled receptors? A signal present on the outside of the cell leads to a change on the inside of the cell.
Where G proteins found and what are their function? ›G-protein coupled receptors are a diverse family of receptors found in a huge range of tissues throughout the body. They function to respond to a wide variety of extracellular signals, such as hormones or neurotransmitters, and trigger intracellular signalling cascades, which regulate a wide range of bodily functions.
Where are G protein coupled receptors found? ›G protein-coupled receptors (GPCRs) are seven-transmembrane proteins that are located in the cell membrane, with their N- and C-termini located on the outer and inner surfaces, respectively. GPCRs mediate various cellular responses from the extracellular environment.
What are some examples of diseases that interfere with G protein function? ›Mutations in GPCR can cause acquired and inherited diseases such as retinitis pigmentosa (RP), hypo- and hyperthyroidism, nephrogenic diabetes insipidus, several fertility disorders, and even carcinomas.
What enzyme is activated by G protein coupled receptors? ›Many G-protein-linked receptors exert their effects mainly via G proteins that activate the plasma-membrane-bound enzyme phospholipase C-β.
What percentage of FDA approved drugs target G protein coupled receptors? ›We estimate that ~700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs. GPCRs and GPCR-related proteins, i.e. those upstream or downstream of GPCRs, represent ~17% of all protein targets for approved drugs, with GPCRs themselves accounting for ~12%.
Are opioid receptors G protein receptors? ›Opioid receptors belong to the class A of G protein-coupled receptors (GPCR) which share some common features. They possess seven transmembrane domains linked by three intracellular and three extracellular loops, an extracellular amino-terminus and an intracytoplasmic C-terminus tail.
What is the difference between G protein and GPCR? ›GPCRs transfer extracellular signals across the plasma membrane to intracellular effectors via G proteins. G proteins belong to the GTPase family and consist of three protein subunits, an α-subunit, a β-subunit and a γ-subunit. The β- and γ-subunits form a stable dimeric complex referred as the βγ-subunit.
What is a GPCR quizlet? ›
G Protein Couples Receptor (GPCR) This cell-surface receptor have seven transmembrane helices, can interact with G proteins via its intracellular loops and C-terminal cytoplasmic tail, and has an extracellular signal molecule binding site.
How many GPCRs are in the human genome? ›The total number of GPCRs with and without introns in the human genome was estimated to be approximately 950, of which 500 are odorant or taste receptors and 450 are receptors for endogenous ligands.
What drugs target G protein receptors? ›Examples of drugs targeting GPCRs include histamine receptor blockers, opioid agonists, β-blockers and angiotensin receptor blockers.
What is the primary role of G protein in the cell? ›G proteins regulate metabolic enzymes, ion channels, transporter proteins, and other parts of the cell machinery, controlling transcription, motility, contractility, and secretion, which in turn regulate diverse systemic functions such as embryonic development, learning and memory, and homeostasis.
Which hormones use G protein coupled receptors? ›Class B G-protein-coupled receptors (GPCRs) are receptors for peptide hormones that include glucagon, parathyroid hormone, and calcitonin. These receptors are involved in a wide spectrum of physiological activities, from metabolic regulation and stress control to development and maintenance of the skeletal system.
What percent of drugs target GPCRs? ›We estimate that ∼700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs. GPCRs and GPCR-related proteins, i.e., those upstream of or downstream from GPCRs, represent ∼17% of all protein targets for approved drugs, with GPCRs themselves accounting for ∼12%.
What are the five main families of G protein coupled receptors in the human genome? ›Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system. The rhodopsin family is the largest and forms four main groups with 13 sub-branches.
What are the five families of GPCRs? ›According to the basis of phylogenetic criteria, human GPCRs can be divided into five main families, including Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2, and Secretin.